Pair of podcasts

WearOptimo has been in good company lately, featuring on two quite varied Australian podcasts – MTPConnect and Fear & Greed. 

Media spotlight: Handy tool for tradies

Summer in Australia can be a nightmare, especially for workers such as tradies, whose jobs may involve spending significant time outside in sweltering temperatures. 

Media spotlight: A conversation about opportunity

WearOptimo CEO and founder Professor Mark Kendall has long seen the opportunities in challenge, such as launching a healthtech business in Brisbane, rather than in a more traditional locale such as Silicon Valley or Geneva.  This made it a perfect theme on which to expand when he was interviewed for the Engineers Australia online news hub Create.

The backing of a proven sporting pedigree

Mark Webber

WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.

A critical conversation with Planet Hope

Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.

Trials attract national attention

In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.

Manufacturing project worth $3.9 million

We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.

$30 million manufacturing project

WearOptimo are delighted to announce our partnership with the Queensland Government, The Australian National University (ANU), The Australian National Fabrication Facility (ANFF), and others in a $30 million project. This project will support the production of our world-leading, lifesaving MicrowearableTM technology at a new Queensland facility which will be key in creating hundreds of high-value jobs throughout this decade. This project aligns with the government’s Queensland Biomedical 10-Year Roadmap and Action Plan to make Queensland a globally competitive Asia-Pacific biomedical hub by 2027.

World-leading, lifesaving wearable medical technology will be produced at a new Queensland facility, supported by an up to $30 million project announced today.